Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · August 27, 2024

Efficacy and Safety of DOACs in the Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension

Respiratory Medicine

 

Additional Info

Respiratory Medicine
Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: A retrospective cohort study
Respir Med 2024 Sep 01;231(xx)107722, LT Chong, S Hu, TT Guo, X Gao, JS Tan, ZQ Liu, YR Deng, YX Wei, L Hua

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading